These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
252 related items for PubMed ID: 6260657
1. Type-common and type-specific monoclonal antibody to herpes simplex virus type 1. Pereira L, Klassen T, Baringer JR. Infect Immun; 1980 Aug; 29(2):724-32. PubMed ID: 6260657 [Abstract] [Full Text] [Related]
2. Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease. Dix RD, Pereira L, Baringer JR. Infect Immun; 1981 Oct; 34(1):192-9. PubMed ID: 6271681 [Abstract] [Full Text] [Related]
3. Antigenic variants of herpes simplex virus selected with glycoprotein-specific monoclonal antibodies. Holland TC, Marlin SD, Levine M, Glorioso J. J Virol; 1983 Feb; 45(2):672-82. PubMed ID: 6187935 [Abstract] [Full Text] [Related]
4. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB. Kitamura K, Namazue J, Campo-Vera H, Ogino T, Yamanishi K. Virology; 1986 Feb; 149(1):74-82. PubMed ID: 2418583 [Abstract] [Full Text] [Related]
5. Mouse hybrid cell lines produce antibodies to herpes simplex virus type 1. Howes EL, Clark EA, Smith E, Mitchison NA. J Gen Virol; 1979 Jul; 44(1):81-7. PubMed ID: 228002 [Abstract] [Full Text] [Related]
6. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis. Ritchie MH, Oakes JE, Lausch RN. Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037 [Abstract] [Full Text] [Related]
7. Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection. Chan WL, Lukig ML, Liew FY. J Exp Med; 1985 Oct 01; 162(4):1304-18. PubMed ID: 2995536 [Abstract] [Full Text] [Related]
8. Production of hybrid cell lines secreting antibodies to herpes simplex virus type 2. Killington RA, Newhook L, Balachandran N, Rawls WE, Bacchetti S. J Virol Methods; 1981 Mar 01; 2(4):223-36. PubMed ID: 6262346 [Abstract] [Full Text] [Related]
9. Protective immunization of mice with specific HSV-1 glycoproteins. Chan WL. Immunology; 1983 Jun 01; 49(2):343-52. PubMed ID: 6303950 [Abstract] [Full Text] [Related]
10. Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type 1 infection. Rector JT, Lausch RN, Oakes JE. Infect Immun; 1982 Oct 01; 38(1):168-74. PubMed ID: 6292092 [Abstract] [Full Text] [Related]
11. Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge. Roberts PL, Duncan BE, Raybould TJ, Watson DH. J Gen Virol; 1985 May 01; 66 ( Pt 5)():1073-85. PubMed ID: 2582080 [Abstract] [Full Text] [Related]
12. Type specificity of complement-fixing antibody against herpes simplex virus type 2 AG-4 early antigen in patients with asymptomatic infection. Sherlock CH, Ashley RL, Shurtleff ML, Mack KD, Corey L. J Clin Microbiol; 1986 Dec 01; 24(6):1093-7. PubMed ID: 3023439 [Abstract] [Full Text] [Related]
13. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1. Wang K, Tomaras GD, Jegaskanda S, Moody MA, Liao HX, Goodman KN, Berman PW, Rerks-Ngarm S, Pitisuttithum P, Nitayapan S, Kaewkungwal J, Haynes BF, Cohen JI. J Virol; 2017 Oct 01; 91(19):. PubMed ID: 28701403 [Abstract] [Full Text] [Related]
14. Type-common and type-specific monoclonal antibodies to herpes simplex virus types 1 and 2. Bystrická M, Vancíková M, Kasalová M, Rajcáni J, Kostál M, Murányiová M, Poláková K, Russ G. Acta Virol; 1991 Apr 01; 35(2):152-64. PubMed ID: 1681713 [Abstract] [Full Text] [Related]
15. Identification and preliminary mapping with monoclonal antibodies of a herpes simplex virus 2 glycoprotein lacking a known type 1 counterpart. Roizman B, Norrild B, Chan C, Pereira L. Virology; 1984 Feb 01; 133(1):242-7. PubMed ID: 6199891 [Abstract] [Full Text] [Related]
16. Competitive inhibition by human sera of mouse monoclonal antibody binding to glycoproteins C and D of herpes simplex virus types 1 and 2. Ross C, Glorioso J, Sacks S, Lavery C, Rawls WE. J Virol; 1985 Jun 01; 54(3):851-5. PubMed ID: 2582149 [Abstract] [Full Text] [Related]
17. Antiviral activities of human monoclonal antibodies to herpes simplex virus. Fujinaga S, Sugano T, Matsumoto Y, Masuho Y, Mori R. J Infect Dis; 1987 Jan 01; 155(1):45-53. PubMed ID: 3025308 [Abstract] [Full Text] [Related]
18. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants. Bishop GA, Marlin SD, Schwartz SA, Glorioso JC. J Immunol; 1984 Oct 01; 133(4):2206-14. PubMed ID: 6206157 [Abstract] [Full Text] [Related]
19. Application of denatured, electrophoretically separated, and immobilized lysates of herpes simplex virus-infected cells for detection of monoclonal antibodies and for studies of the properties of viral proteins. Braun DK, Pereira L, Norrild B, Roizman B. J Virol; 1983 Apr 01; 46(1):103-12. PubMed ID: 6298448 [Abstract] [Full Text] [Related]